Combination of In Silico Methods in the Search for Potential CD4+ and CD8+ T Cell Epitopes in the Proteome of Leishmania braziliensis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of In Silico Methods in the Search for Potential CD4+ and CD8+ T Cell Epitopes in the Proteome of Leishmania braziliensis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-08-29
DOI
10.3389/fimmu.2016.00327
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease
- (2016) Marina A. Souza et al. IMMUNOBIOLOGY
- HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms
- (2015) Rodrigo dos Santos Francisco et al. IMMUNOGENETICS
- Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation
- (2015) Angelo Duarte et al. PLoS One
- Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4 + T cells
- (2015) Zhirong Mou et al. Science Translational Medicine
- Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production
- (2015) Patricio Oyarzún et al. Human Vaccines & Immunotherapeutics
- Leishmania braziliensis Infection Induces Dendritic Cell Activation, ISG15 Transcription, and the Generation of Protective Immune Responses
- (2014) D. A. Vargas-Inchaustegui et al. JOURNAL OF IMMUNOLOGY
- From Genome Screening to Creation of Vaccine AgainstTrypanosoma cruziby Use of Immunoinformatics
- (2014) Christian Teh-Poot et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem
- (2014) David L Sacks NATURE IMMUNOLOGY
- Using Humans to Make a Human Leishmaniasis Vaccine
- (2014) S. Kamhawi et al. Science Translational Medicine
- Global distribution maps of the leishmaniases
- (2014) David M Pigott et al. eLife
- Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
- (2014) Maria Agallou et al. Frontiers in Immunology
- PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity
- (2013) Patricio Oyarzún et al. BMC BIOINFORMATICS
- Sequence variations of the MHC class I gene exon 2 and exon 3 between infected and uninfected chickens challenged with Marek’s disease virus
- (2013) Ye Wang et al. INFECTION GENETICS AND EVOLUTION
- Cytokines and NO in American tegumentary leishmaniasis patients: Profiles in active disease, after therapy and in self-healed individuals
- (2013) Marina de Assis Souza et al. MICROBIAL PATHOGENESIS
- Reassessing buried surface areas in protein-protein complexes
- (2013) Devlina Chakravarty et al. PROTEIN SCIENCE
- New vaccines for neglected parasitic diseases and dengue
- (2013) Coreen M. Beaumier et al. Translational Research
- T-cell epitope vaccine design by immunoinformatics
- (2013) A. Patronov et al. Open Biology
- Re-Directing CD4+ T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough
- (2013) Christopher J. Holland et al. Frontiers in Immunology
- A Reverse Vaccinology Approach for the Identification of Potential Vaccine Candidates from Leishmania spp
- (2012) Lijo John et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- An assessment on epitope prediction methods for protozoa genomes
- (2012) Daniela M Resende et al. BMC BIOINFORMATICS
- Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure
- (2012) Maria Carolina Accioly Brelaz-de-Castro et al. CELLULAR IMMUNOLOGY
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Christopher J L Murray et al. LANCET
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response
- (2011) Negar Seyed et al. PLoS Neglected Tropical Diseases
- Vaccines for the Leishmaniases: Proposals for a Research Agenda
- (2011) et al. PLoS Neglected Tropical Diseases
- Innate Immunity and Leishmania Vaccination Strategies
- (2010) Ron Birnbaum et al. DERMATOLOGIC CLINICS
- Role of chemokines in regulation of immunity against leishmaniasis
- (2010) Steve Oghumu et al. EXPERIMENTAL PARASITOLOGY
- Sub-angstrom modeling of complexes between flexible peptides and globular proteins
- (2010) Barak Raveh et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Adaptive Immunity against Leishmania Nucleoside Hydrolase Maps Its C-Terminal Domain as the Target of the CD4+ T Cell–Driven Protective Response
- (2010) Dirlei Nico et al. PLoS Neglected Tropical Diseases
- NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction
- (2009) Morten Nielsen et al. BMC BIOINFORMATICS
- TriTrypDB: a functional genomic resource for the Trypanosomatidae
- (2009) Martin Aslett et al. NUCLEIC ACIDS RESEARCH
- HLA class I supertypes: a revised and updated classification
- (2008) John Sidney et al. BMC IMMUNOLOGY
- An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection
- (2008) F.Z. Guerfali et al. INFECTION GENETICS AND EVOLUTION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started